Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GH Guardant Health Inc.

Not Yet Opened 10-15 16:00:00 EDT

165.88

+2.89

+1.77%

盘后165.12

-0.76-0.46%

19:57 EDT

High168.86	Low159.00	Vol1.33M
Open160.78	D1 Closing162.99	Amplitude6.05%
Mkt Cap22.26B	Tradable Cap21.53B	Total Shares134.20M
T/O220.29M	T/O Rate1.02%	Tradable Shares129.78M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GH","market":"US","secType":"STK","nameCN":"Guardant Health Inc.","latestPrice":165.88,"timestamp":1792094400000,"preClose":162.99,"halted":0,"volume":1329362,"hourTrading":{"tag":"盘后","latestPrice":165.1206,"preClose":165.88,"latestTime":"19:57 EDT","volume":20229,"amount":3355776.3228,"timestamp":1792108653986,"change":-0.7594,"changeRate":-0.004578,"amplitude":0.005301},"delay":0,"changeRate":0.017731149150254533,"floatShares":129778058,"shares":134196170,"eps":-3.503749,"marketStatus":"Not Yet Opened","change":2.89,"latestTime":"10-15 16:00:00 EDT","open":160.78,"high":168.86,"low":158.998,"amount":220291448.44192,"amplitude":0.060507,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.503749,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1792137600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":162.99,"preHourTrading":{"tag":"盘前","latestPrice":163,"preClose":162.99,"latestTime":"09:23 EDT","volume":2889,"amount":469168.28423999995,"timestamp":1792070634521,"change":0.01,"changeRate":0.000061,"amplitude":0.032211},"postHourTrading":{"tag":"盘后","latestPrice":165.1206,"preClose":165.88,"latestTime":"19:57 EDT","volume":20229,"amount":3355776.3228,"timestamp":1792108653986,"change":-0.7594,"changeRate":-0.004578,"amplitude":0.005301},"volumeRatio":0.916508,"impliedVol":0.7107,"impliedVolPercentile":0.8167},"requestUrl":"/m/hq/s/GH/","defaultTab":"news","newsList":[{"id":"2675553359","title":"Guardant Health Director Alex M. Azar II Reports Disposal of $11,032.41 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2675553359","media":"Reuters","labels":["insiderTrades","express"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2675553359?lang=en_us&edition=fundamental","pubTime":"2026-10-16 06:03","pubTimestamp":1792101810,"startTime":"0","endTime":"0","summary":"Guardant Health Director Alex M. Azar II Reports Disposal of $11,032.41 in Common SharesGuardant Health director Alex M. Azar II sold 69 shares of common stock on Oct. 14, 2026.The sale price was $159","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nNDL2KF22v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Alex M. Azar II Reports Disposal of $11,032.41 in Common Shares","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4535","GDOC","LU0320765992.SGD","BK4196","PTH","BK4551","EKG","LU0889565916.HKD","GH","BK4585","BK4588","LFSC","GNOM","GNMX","FFOX","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675053029","title":"Guardant Health's Duplex Sequencing Patent Challenge Rejected by Appeal Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2675053029","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675053029?lang=en_us&edition=fundamental","pubTime":"2026-10-16 04:47","pubTimestamp":1792097241,"startTime":"0","endTime":"0","summary":"Guardant Health's  challenge to all 30 claims of a US patent underlying duplex sequencing and owned by the University of Washington was rejected by the Patent Trial and Appeal Board, TwinStrand Biosciences, the patent's exclusive licensee, said Thursday.The board determined Guardant \"failed to establish the unpatentability\" of any of the challenged claims, TwinStrand said in a statement.The patent is one of two at issue in infringement litigation TwinStrand brought against Guardant in the US District Court for the District of Delaware, according to the statement.The ruling preserved a November 2023 jury verdict that Guardant \"willfully infringed\" the patent and awarded more than $245.2 million in damages, accrued royalties and interest through May 2026, TwinStrand said.Guardant was also directed to pay an ongoing royalty of 6% on all covered products and services through March 2033, TwinStrand said.Guardant did not immediately respond to a request for comment from MT Newswires.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GNMX","GNOM","LFSC","HELX","LU0889565916.HKD","BK4588","GDOC","PTH","LU0109394709.USD","FFOX","GH","LU0320765992.SGD","BK4535","USRD","BK4551","EKG","BK4585","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675840005","title":"Guardant presents data from role of blood-based testing in CRC screening","url":"https://stock-news.laohu8.com/highlight/detail?id=2675840005","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675840005?lang=en_us&edition=fundamental","pubTime":"2026-10-15 20:21","pubTimestamp":1792066868,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced the company and its research collaborators presented new data showing the critical role of blood-based testing in in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-presents-data-from-role-of-blood-based-testing-in-crc-screening-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-presents-data-from-role-of-blood-based-testing-in-crc-screening-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","GNOM","LU0889565916.HKD","LU0320765992.SGD","BK4535","FFOX","BK4588","LU0109394709.USD","PTH","LU0456854461.SGD","BK4213","BK4196","GH","CRC","GDOC","EKG","HELX","BK4551","LU0266512127.USD","LFSC","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675841755","title":"Guardant Health's Shield Blood Test Achieves 99% Screening Adherence in Rural Clinic Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2675841755","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675841755?lang=en_us&edition=fundamental","pubTime":"2026-10-15 20:14","pubTimestamp":1792066463,"startTime":"0","endTime":"0","summary":"Guardant Health's Shield Blood Test Achieves 99% Screening Adherence in Rural Clinic StudyGuardant Health presented Shield colorectal cancer blood test research at the American College of Gastroentero","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nNDL2mCxTJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4196","LU0109394709.USD","LU0320765992.SGD","BK4551","BK4535","BK4585","LU0889565916.HKD","BK4588","HELX","EKG","LFSC","GDOC","GNMX","GH","FFOX","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675343093","title":"Analysts’ Top Healthcare Picks: Agilent (A), Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2675343093","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675343093?lang=en_us&edition=fundamental","pubTime":"2026-10-14 18:40","pubTimestamp":1791974415,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Agilent (A) and Guardant Health (GH) with bullish se...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-agilent-a-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-agilent-a-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0029874061.USD","LU1543694498.USD","LU0320765992.SGD","LU2089279066.USD","PTH","LU2491050154.USD","GH","IE00BN0W2V16.EUR","LU1721429402.USD","LU0889565916.HKD","BK4585","LU2491049909.HKD","LU0347712357.USD","HELX","LU0109394709.USD","BK4535","BK4196","HCSG","LU2041044095.USD","BK4581","BK4137","BK4121","LU1721428933.USD","LU1721429741.USD","LU2413666426.HKD","LU2413666699.HKD","LU2491050071.SGD","GNMX","IE00BN0W2W23.USD","FFOX","LFSC","A","LU1165135440.EUR","XLV","BK4567","EKG","LABU","IE00BN0W2T93.GBP","LU0128526141.USD","LU2229751404.USD","XBI","LU2092937221.SGD","GNOM","BK4551","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675349369","title":"How to Read Your Body's Warning Signs Years Before You Get Sick","url":"https://stock-news.laohu8.com/highlight/detail?id=2675349369","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675349369?lang=en_us&edition=fundamental","pubTime":"2026-10-14 01:22","pubTimestamp":1791912120,"startTime":"0","endTime":"0","summary":"If the risk of cancer, heart disease or another debilitating disease became real tomorrow, I ask patients what they wish they would had done todayWe can learn to recognize warning signs before they be","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","VHT","EKG","LU0109394709.USD","GH","BK4585","GNOM","BK4550","BK4196","LU0889565916.HKD","GDOC","LU0320765992.SGD","FFOX","GNMX","HELX","LFSC","BK4535","BK4588","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151232157","title":"Movement Alert｜Guardant Health Inc. Intraday Decline 5.16%, Patent Litigation Loss and Royalty Burden Continue to Pressure Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1151232157","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151232157?lang=en_us&edition=fundamental","pubTime":"2026-10-13 01:15","pubTimestamp":1791825341,"startTime":"0","endTime":"0","summary":"On October 13, Guardant Health Inc. fell 5.16% in regular trading to $158.81 per share, with turnover of $107 million. The decline reflects ongoing market digestion of a significant patent...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Slumps After $245.2M Patent Damages Ruling","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674038718","title":"Guardant Health price target raised to $200 from $185 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2674038718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674038718?lang=en_us&edition=fundamental","pubTime":"2026-10-12 21:25","pubTimestamp":1791811530,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Kallum Titchmarsh raised the firm’s price target on Guardant Health (GH) to $200 from $185 and keeps an Overweight rating on...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-200-from-185-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-200-from-185-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FFOX","HELX","PTH","EKG","GH","BK4535","BK4588","LU0109394709.USD","GNOM","GNMX","LU0889565916.HKD","BK4196","GDOC","LU0320765992.SGD","BK4551","BK4585","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674000684","title":"Guardant announces Europe approval of Guardnat360 CDx as Etcamaha companion","url":"https://stock-news.laohu8.com/highlight/detail?id=2674000684","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674000684?lang=en_us&edition=fundamental","pubTime":"2026-10-09 04:15","pubTimestamp":1791490537,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced that Guardant360 CDx has received CE-marking under Europe’s in Vitro Diagnostic Medical Devices Regulation as a comp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-announces-europe-approval-of-guardnat360-cdx-as-etcamaha-companion-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-announces-europe-approval-of-guardnat360-cdx-as-etcamaha-companion-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTH","LU0889565916.HKD","BK4551","BK4585","BK4588","GH","GNMX","LFSC","GNOM","BK4535","LU0320765992.SGD","FFOX","EKG","LU0109394709.USD","GDOC","BK4196","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674000800","title":"Guardant Health Wins EU CE Mark for Guardant360 CDx as Camizestrant Companion Diagnostic in ER-Positive Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2674000800","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674000800?lang=en_us&edition=fundamental","pubTime":"2026-10-09 04:12","pubTimestamp":1791490344,"startTime":"0","endTime":"0","summary":"Guardant Health wins EU CE mark for Guardant360 CDx as camizestrant companion diagnostic in ER-positive breast cancerGuardant Health secured EU CE-marking for Guardant360 CDx as a companion diagnostic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL7WpmQr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","BK4196","LU0109394709.USD","EKG","BK4551","LU0320765992.SGD","GNMX","BK4535","HELX","FFOX","LU0889565916.HKD","GDOC","GH","PTH","BK4585","GNOM","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674802000","title":"Guardant Health Announces Approval in Europe of Guardant360® Cdx as Companion Diagnostic for AstraZeneca’s Etcamah™ (Camizestrant) in Advanced Er-Positive Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2674802000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674802000?lang=en_us&edition=fundamental","pubTime":"2026-10-09 04:12","pubTimestamp":1791490320,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nTUA8LV3XK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GDOC","LU1481599808.USD","LU0997586515.USD","LU2237443622.USD","03165","LFSC","LU2023251221.USD","LU0960981461.USD","LU0949170772.SGD","LU0011850046.USD","LU1323610961.USD","EKG","LU0058720904.USD","LU0823416689.USD","LU0827474353.SGD","IE00B3T34201.USD","IE00BJT1NW94.SGD","HELX","GNOM","LU0972486137.USD","LU1153585028.USD","PTH","LU0784383803.USD","LU0029864427.USD","LU0211326755.USD","LU1863844749.USD","LU1496350171.SGD","LU1923622614.USD","LU1267930813.SGD","LU1989772923.USD","LU0949170426.SGD","LU0823399737.USD","LU1057294990.SGD","LU0882574055.USD","AZN.UK","LU0757432116.USD","LU2293690249.USD","LU2539964713.USD","LU0784385840.USD","LU0661504455.SGD","LU1261432733.SGD","LU0345777659.USD","LU1015430645.USD","FFOX","LU2125909247.SGD","GH","GNMX","LU0345777147.USD","LU0526926950.USD","LU1153584641.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674007701","title":"Guardant Health to Report Q3 2026 Financial Results After Market Close, Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2674007701","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674007701?lang=en_us&edition=fundamental","pubTime":"2026-10-09 04:05","pubTimestamp":1791489926,"startTime":"0","endTime":"0","summary":"Guardant Health to report Q3 2026 financial results after market close, host conference callGuardant Health schedules third-quarter 2026 results release for Nov. 5, 2026, following the market close.Ma","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDLWjfQL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","FFOX","GNMX","BK4585","GH","EKG","GDOC","HELX","LU0109394709.USD","LU0889565916.HKD","PTH","LU0320765992.SGD","BK4551","LFSC","BK4535","BK4588","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673162670","title":"Guardant Health is Maintained at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2673162670","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673162670?lang=en_us&edition=fundamental","pubTime":"2026-10-07 22:43","pubTimestamp":1791384180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0889565916.HKD","BK4196","BK4535","EKG","FFOX","BK4588","GH","GDOC","GNMX","HELX","GNOM","LU0320765992.SGD","PTH","BK4585","LFSC","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673965070","title":"Barclays Sticks to Its Buy Rating for Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673965070","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673965070?lang=en_us&edition=fundamental","pubTime":"2026-10-07 15:58","pubTimestamp":1791359934,"startTime":"0","endTime":"0","summary":"In a report released today, Luke Sergott from Barclays maintained a Buy rating on Guardant Health, with a price target of $220.00. Sergott covers t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-guardant-health-gh-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-guardant-health-gh-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673068758","title":"Guardant Health Inc Stock (GH) Moved Down by 8.27% on Oct 6: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2673068758","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673068758?lang=en_us&edition=fundamental","pubTime":"2026-10-07 03:15","pubTimestamp":1791314128,"startTime":"0","endTime":"0","summary":"• Guardant Health shares dropped due to profit-taking after a multi-month rally.\n• Ongoing unprofitability and high valuation multiples triggered intense selling pressure.\n• The company reported $982.02M in annual revenue and a net profit of $-416.28M.","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262202416-market-movers-gh-20261006","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","LU0889565916.HKD","BK4551","BK4585","BK4588","GH","GNMX","LFSC","GNOM","BK4535","LU0320765992.SGD","FFOX","EKG","LU0109394709.USD","GDOC","BK4196","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197717535","title":"Movement Alert｜Guardant Health Inc. Falls 5.36% in Regular Trading, Profit-Taking After Multi-Catalyst Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1197717535","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197717535?lang=en_us&edition=fundamental","pubTime":"2026-10-06 22:13","pubTimestamp":1791296035,"startTime":"0","endTime":"0","summary":"On October 6, Guardant Health Inc. fell 5.36% in regular trading, trading at $177.2 per share with turnover of $118 million. The decline followed a prior-session gain of 5.30% that pushed the stock...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"UBS Lifts Guardant Health Target to $225 After Pullback","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111351843","title":"Movement Alert｜Guardant Health Inc. Rises 5.07% in Regular Trading, UBS Report Highlights Liquid Biopsy Tailwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=1111351843","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111351843?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:03","pubTimestamp":1791227037,"startTime":"0","endTime":"0","summary":"On October 6, Guardant Health Inc. rose 5.07% in regular trading, trading at $186.87/share, with turnover of $161 million.The intraday gains followed UBS analysis positioning Guardant as a direct...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"UBS Sees Liquid Biopsy Tailwinds Lifting Guardant Health","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673085570","title":"Guardant Health reports COSMOS study published in Cancer Research Communications","url":"https://stock-news.laohu8.com/highlight/detail?id=2673085570","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673085570?lang=en_us&edition=fundamental","pubTime":"2026-10-05 23:30","pubTimestamp":1791214209,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced Cancer Research Communications, a journal of the American Association for Cancer Research, has published results fro...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-reports-cosmos-study-published-in-cancer-research-communications-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-reports-cosmos-study-published-in-cancer-research-communications-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4535","GH","FFOX","LU0109394709.USD","PTH","EKG","BK4585","GDOC","LU0320765992.SGD","LU0889565916.HKD","HELX","LFSC","GNOM","BK4588","BK4196","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673085807","title":"Guardant Health Cosmos-MEL01 Study Shows Guardant Reveal Detects 81% of Distant Melanoma Recurrences","url":"https://stock-news.laohu8.com/highlight/detail?id=2673085807","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673085807?lang=en_us&edition=fundamental","pubTime":"2026-10-05 23:27","pubTimestamp":1791214069,"startTime":"0","endTime":"0","summary":"Guardant Health COSMOS-MEL01 study shows Guardant Reveal detects 81% of distant melanoma recurrencesGuardant Health disclosed published results from a prospective, multicenter COSMOS study evaluating ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL5cqdWm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4535","GH","FFOX","LU0109394709.USD","PTH","EKG","BK4585","GDOC","LU0320765992.SGD","LU0889565916.HKD","HELX","LFSC","GNOM","BK4588","BK4196","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702771","title":"Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702771","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702771?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:00","pubTimestamp":1791201600,"startTime":"0","endTime":"0","summary":"Trial follows promising MAR002 Phase 1 clinical trial results that demonstrated deep and durable IGF-1 suppression with PK properties that may enable dosing as infrequently as once every two weeks, co","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374474/18623/en/marea-therapeutics-a-subsidiary-of-lisata-therapeutics-announces-first-patient-dosed-in-phase-2-clinical-trial-of-mar002-a-potential-best-in-disease-investigational-therapy-for-the.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HELX","FFOX","BK4183","GNMX","LU0320765992.SGD","BK4551","EKG","LU0889565916.HKD","LENZ","BK4588","LFSC","BK4007","BK4196","GH","ENDO","BK4218","GNOM","BK4585","BK4539","GDOC","KBWY","PTH","PK","LU0109394709.USD","BK4139","BK4181","BK4535"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.guardanthealth.com","stockEarnings":[{"period":"1week","weight":-0.0317},{"period":"1month","weight":-0.0289},{"period":"3month","weight":0.0515},{"period":"6month","weight":0.8038},{"period":"1year","weight":1.6053},{"period":"ytd","weight":0.5958}],"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":0.0115},{"period":"3month","weight":0.0251},{"period":"6month","weight":0.0837},{"period":"1year","weight":0.1621},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.071093},{"month":2,"riseRate":0.25,"avgChangeRate":0.034152},{"month":3,"riseRate":0.5,"avgChangeRate":-0.022808},{"month":4,"riseRate":0.375,"avgChangeRate":-0.022604},{"month":5,"riseRate":0.625,"avgChangeRate":0.118443},{"month":6,"riseRate":0.75,"avgChangeRate":0.091261},{"month":7,"riseRate":0.75,"avgChangeRate":0.055},{"month":8,"riseRate":0.5,"avgChangeRate":0.070736},{"month":9,"riseRate":0.375,"avgChangeRate":-0.042394},{"month":10,"riseRate":0.25,"avgChangeRate":0.015799},{"month":11,"riseRate":0.75,"avgChangeRate":0.130427},{"month":12,"riseRate":0.5,"avgChangeRate":-0.066498}],"exchange":"NASDAQ","name":"Guardant Health Inc.","nameEN":"Guardant Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Guardant Health Inc.(GH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Guardant Health Inc.,GH,Guardant Health Inc.股票,Guardant Health Inc.股票老虎,Guardant Health Inc.股票老虎国际,Guardant Health Inc.行情,Guardant Health Inc.股票行情,Guardant Health Inc.股价,Guardant Health Inc.股市,Guardant Health Inc.股票价格,Guardant Health Inc.股票交易,Guardant Health Inc.股票购买,Guardant Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Guardant Health Inc.(GH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}